Energized with Dr. Mariza

709: GLP-1 Medications, Gut Health, and Food as Medicine: A Smarter, Personalized Approach for Women in Midlife with Ashley Koff

Jan 6, 2026
Ashley Koff, a registered dietitian and founder of The Better Nutrition Program, dives into GLP-1 agonists for midlife women, offering a refreshing perspective on their role in metabolic health. She addresses common stigma, emphasizing self-advocacy and the importance of personalized nutrition. Ashley highlights practical strategies for optimizing hormone health and discusses how GLP-1s can influence athletic performance and address weight-health issues. With her extensive experience, she encourages listeners to listen to their bodies and make informed health choices.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Personal Journey From Digestive Issues To Hormones

  • Ashley Koff shared her lifelong struggle with digestion, antibiotics, and weight that reframed her approach to nutrition and hormones.
  • Meeting a gastroenterologist who said her body lacked what it needed changed her trajectory toward focusing on incretin and weight-health hormones.
INSIGHT

Incretins Are Key Weight‑Health Signalers

  • GLP-1 and related incretin hormones are central regulators of appetite, blood sugar, and body composition beyond simple willpower narratives.
  • Semaglutide and tirzepatide are biosimilar agonists that act differently than bioidentical hormones and thus require nuanced understanding.
INSIGHT

Medication Reveals Social Weight Bias

  • GLP-1 agonists revealed cultural weight bias and provoked judgment toward users rather than constructive health conversations.
  • Many people experienced steady, sustainable weight loss when supported by holistic care rather than instant celebrity-driven narratives.
Get the Snipd Podcast app to discover more snips from this episode
Get the app